{"id":1001713,"date":"2026-09-09T08:01:08","date_gmt":"2026-09-09T12:01:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\/"},"modified":"2026-09-09T08:01:08","modified_gmt":"2026-09-09T12:01:08","slug":"eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\/","title":{"rendered":"Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society"},"content":{"rendered":"
\n

IRVINE, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (\u201cEledon\u201d) (Nasdaq: ELDN) today announced an oral presentation highlighting the long-term safety and efficacy of tegoprubart in preventing kidney transplant rejection will take place at the upcoming International Congress of The Transplantation Society in Sydney, Australia, from September 20\u201323, 2026.<\/p>\n

Details of the presentation are below:<\/p>\n

\n Oral Presentation<\/u>\n <\/p>\n

\n Title:<\/strong>\u00a0Phase 2 BESTOW trial and the BESTOW EXTENSION: Evaluating the long-term safety and efficacy of tegoprubart in preventing kidney transplant rejection<\/p>\n

\n Presenter:\u00a0<\/strong>Andrew Adams, M.D., Ph.D., Professor of Surgery and Chief Division of Transplantation, John S. Najarian Surgical Chair in Clinical Transplantation,\u00a0Department of Surgery,\u00a0University of Minnesota; Executive Medical Director, Solid Organ Transplant Service Line, M Health Fairview<\/p>\n

\n Session Title:\u00a0<\/strong>Novel immunosuppression<\/p>\n

\n Session Date and Time:<\/strong>\u00a0Tuesday, September 22, 2026, from 8:00AM to 9:00AM AEST<\/p>\n

\n Session Room:\u00a0<\/strong>Room C4.9<\/p>\n

\n Presentation Time:<\/strong>\u00a08:00AM AEST<\/p>\n

\n About\u00a0Eledon Pharmaceuticals\u00a0and tegoprubart<\/strong>\n <\/p>\n

Eledon Pharmaceuticals, Inc.\u00a0is a clinical stage biotechnology company that is developing immune-modulating therapies for the management and treatment of life-threatening conditions. The Company\u2019s lead investigational product is tegoprubart, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential. The central role of CD40L signaling in both adaptive and innate immune cell activation and function positions it as an attractive target for non-lymphocyte depleting, immunomodulatory therapeutic intervention. The Company is building upon a deep historical knowledge of anti-CD40L biology to conduct preclinical and clinical studies in kidney allograft transplantation, xenotransplantation, islet cell transplantation, liver transplantation and amyotrophic lateral sclerosis (ALS). Eledon is headquartered in\u00a0Irvine, California. For more information, please visit the Company\u2019s website at\u00a0www.eledon.com<\/a>.<\/p>\n

Follow\u00a0Eledon Pharmaceuticals\u00a0on social media:\u00a0LinkedIn<\/a>;\u00a0X<\/a><\/p>\n

\n Investor Contact:<\/strong>\n <\/p>\n

Stephen Jasper
Gilmartin Group
(858) 525 2047
stephen@gilmartinir.com<\/a><\/p>\n

\n Media Contact:<\/strong>\n <\/p>\n

Jenna Urban
CG Life
(212) 253 8881
jurban@cglife.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

IRVINE, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (\u201cEledon\u201d) (Nasdaq: ELDN) today announced an oral presentation highlighting the long-term safety and efficacy of tegoprubart in preventing kidney transplant rejection will take place at the upcoming International Congress of The Transplantation Society in Sydney, Australia, from September 20\u201323, 2026. Details of the presentation are below: Oral Presentation Title:\u00a0Phase 2 BESTOW trial and the BESTOW EXTENSION: Evaluating the long-term safety and efficacy of tegoprubart in preventing kidney transplant rejection Presenter:\u00a0Andrew Adams, M.D., Ph.D., Professor of Surgery and Chief Division of Transplantation, John S. Najarian Surgical Chair in Clinical Transplantation,\u00a0Department of Surgery,\u00a0University of Minnesota; Executive Medical Director, Solid Organ Transplant Service Line, M Health Fairview Session Title:\u00a0Novel immunosuppression Session Date … <\/p>\n

Continue reading “Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1001713","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nEledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"IRVINE, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (\u201cEledon\u201d) (Nasdaq: ELDN) today announced an oral presentation highlighting the long-term safety and efficacy of tegoprubart in preventing kidney transplant rejection will take place at the upcoming International Congress of The Transplantation Society in Sydney, Australia, from September 20\u201323, 2026. Details of the presentation are below: Oral Presentation Title:\u00a0Phase 2 BESTOW trial and the BESTOW EXTENSION: Evaluating the long-term safety and efficacy of tegoprubart in preventing kidney transplant rejection Presenter:\u00a0Andrew Adams, M.D., Ph.D., Professor of Surgery and Chief Division of Transplantation, John S. Najarian Surgical Chair in Clinical Transplantation,\u00a0Department of Surgery,\u00a0University of Minnesota; Executive Medical Director, Solid Organ Transplant Service Line, M Health Fairview Session Title:\u00a0Novel immunosuppression Session Date … Continue reading "Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-09T12:01:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMzQwNyM3ODIzODgyIzIwMDY1NTA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society\",\"datePublished\":\"2026-09-09T12:01:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\\\/\"},\"wordCount\":312,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMzQwNyM3ODIzODgyIzIwMDY1NTA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\\\/\",\"name\":\"Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMzQwNyM3ODIzODgyIzIwMDY1NTA=\",\"datePublished\":\"2026-09-09T12:01:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMzQwNyM3ODIzODgyIzIwMDY1NTA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMzQwNyM3ODIzODgyIzIwMDY1NTA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\/","og_locale":"en_US","og_type":"article","og_title":"Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society - Market Newsdesk","og_description":"IRVINE, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (\u201cEledon\u201d) (Nasdaq: ELDN) today announced an oral presentation highlighting the long-term safety and efficacy of tegoprubart in preventing kidney transplant rejection will take place at the upcoming International Congress of The Transplantation Society in Sydney, Australia, from September 20\u201323, 2026. Details of the presentation are below: Oral Presentation Title:\u00a0Phase 2 BESTOW trial and the BESTOW EXTENSION: Evaluating the long-term safety and efficacy of tegoprubart in preventing kidney transplant rejection Presenter:\u00a0Andrew Adams, M.D., Ph.D., Professor of Surgery and Chief Division of Transplantation, John S. Najarian Surgical Chair in Clinical Transplantation,\u00a0Department of Surgery,\u00a0University of Minnesota; Executive Medical Director, Solid Organ Transplant Service Line, M Health Fairview Session Title:\u00a0Novel immunosuppression Session Date … Continue reading \"Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-09T12:01:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMzQwNyM3ODIzODgyIzIwMDY1NTA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society","datePublished":"2026-09-09T12:01:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\/"},"wordCount":312,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMzQwNyM3ODIzODgyIzIwMDY1NTA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\/","name":"Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMzQwNyM3ODIzODgyIzIwMDY1NTA=","datePublished":"2026-09-09T12:01:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMzQwNyM3ODIzODgyIzIwMDY1NTA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMzQwNyM3ODIzODgyIzIwMDY1NTA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-announces-presentation-at-the-international-congress-of-the-transplantation-society\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1001713","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1001713"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1001713\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1001713"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1001713"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1001713"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}